Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Ann Surg Oncol. 2023 Aug;30(8):4876-4885. doi: 10.1245/s10434-023-13494-4. Epub 2023 May 3.
This study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after radical surgery of hepatocellular carcinoma (HCC).
A retrospective analysis of 296 patients with HCC who underwent radical resection was performed. On the basis of LI-RADS, tumor imaging morphology was classified into three types. The clinical imaging features, ER, and survival rates of three types were compared. Univariate and multivariate Cox regression analyses were conducted to identify prognostic factors associated with OS and ER after hepatectomy for HCC.
There were 167 tumors of type 1, 95 of type 2, and 34 of type 3. In patients with type 3 HCC, postoperative mortality and ER were significantly higher than in patients with type 1 and type 2 (55.9% versus 32.6% versus 27.5% and 52.9% versus 33.7% versus 28.7%). In multivariate analysis, the LI-RADS morphological type was a stronger risk factor for predicting poor OS [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.59-4.85, P < 0.001] and ER (HR 2.14, 95% CI 1.24-3.70, P = 0.007). A subgroup analysis revealed that type 3 was associated with poor OS and ER in > 5 cm cases but not in < 5 cm cases.
ER and OS of patients with HCC undergoing radical surgery can be predicted using the preoperative tumor LI-RADS morphological type, which could help to select personalized treatment plans for patients with HCC in the future.
本研究旨在探讨术前磁共振成像(MRI)肿瘤形态学分类与肝癌(HCC)根治性手术后早期复发(ER)和总生存(OS)的关系。
回顾性分析 296 例接受根治性切除术的 HCC 患者。基于 LI-RADS,将肿瘤影像学形态分为 3 型。比较三种类型的临床影像学特征、ER 和生存率。采用单因素和多因素 Cox 回归分析确定与 HCC 肝切除术后 OS 和 ER 相关的预后因素。
1 型肿瘤 167 个,2 型肿瘤 95 个,3 型肿瘤 34 个。3 型 HCC 患者术后死亡率和 ER 明显高于 1 型和 2 型(55.9%比 32.6%比 27.5%和 52.9%比 33.7%比 28.7%)。多因素分析显示,LI-RADS 形态类型是预测不良 OS 的更强危险因素[风险比(HR)2.77,95%置信区间(CI)1.59-4.85,P<0.001]和 ER(HR 2.14,95%CI 1.24-3.70,P=0.007)。亚组分析显示,3 型与>5 cm 病例的不良 OS 和 ER 相关,但与<5 cm 病例无关。
术前肿瘤 LI-RADS 形态类型可预测 HCC 根治性手术患者的 ER 和 OS,有助于为 HCC 患者选择个体化治疗方案。